Hospitals and Health Systems
Featured Topics
Lead story
Other featured articles
-
Affordable Care Act Exchange Plans Negotiate Lower Hospital Prices Than Commercial Plans, According to New Schaeffer Center Analysis
ACA exchange plans on average paid 89% of what commercial group plans paid for both inpatient and outpatient procedures.
Posted in -
Insurers Negotiate Lower Hospital Prices for HIX Than for Commercial Groups
USC researches compare health insurance exchange plans, commercial plans and Medicare Advantage plans.
Posted in -
Price Changes Varied Widely Across California Hospital Systems from 2012 through 2018
Researchers compared prices changes within system and nonsystem hospitals in California.
Posted in -
Are California Hospital Systems Rapidly Increasing Prices? The Data Suggest Not All Systems Are Alike
Average price growth was high among California for-profit systems (31% over the study period), while non-profit and public systems had lower average price growth (13%) than nonsystem hospitals (15%).
Posted in
About this section
Hospitals and healthcare systems are under increasing pressure to improve outcomes while reducing costs. This comes as they are also grappling with policy changes, new technologies, and an aging population. Schaeffer Center researchers are analyzing these effects and what they mean for healthcare and health outcomes overall.
Our Work In Hospitals and Health Systems
-
Rapid Growth in Oncology Practices Directly Dispensing Cancer Drugs
Medically integrated dispensing allows oncology practices to dispense oral anticancer drugs at their practices in onsite pharmacies.
Categorized in -
A Tale of Two Trials: A Comparative Case Study of Successful Versus Terminated Home-Based Palliative Care Trials
In 2007 we published a trial of home-based palliative care (HBPC) conducted in a managed care organization (MCO) that found significant improvements in patient satisfaction with health care, rates of home deaths, and reductions in health care use and costs.
Categorized in -
Electronic ‘Nudges’ May Improve Safety in Opioid Prescribing Among California Doctors, Study Finds
Researchers observed a 23% drop in opioid prescriptions and a 27% increase in prescriptions for naloxone.
Categorized in -
Value Defects In The Health Services Sector
As of 2021, US health care expenditures exceed $3.8 trillion. It’s no secret that health care is nearly as wasteful in spending on value defects—behaviors that needlessly reduce quality, negatively impact the patient experience, or add to total costs of care—as it is in delivering clinical benefits.
Categorized in -
Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis
This study aimed to assess the cost-effectiveness of fibrosis-based direct-acting antiviral treatment policies for patients with chronic hepatitis C virus at the Kaiser Permanente Mid-Atlantic States health system.
Categorized in -
Assessing the Use of Data Systems to Estimate Return-on-Investment of Behavioral Healthcare Interventions: Opportunities and Barriers
America is facing a behavioral health crisis, both in terms of increasing prevalence rates and high behavioral healthcare needs.
Categorized in